Skip to main content
VCbacked
Log inGet Started

PineTree Therapeutics

Cambridge, United States

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

$47.0M raised
Oct 2025
Series B
BiotechnologyMedicalOncologyTherapeuticsWellness

Top Investors

Smilegate InvestmentKorea Investment PartnersSGI Venture CapitalSTIC InvestmentInterVest Co.

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about PineTree Therapeutics

How much funding has PineTree Therapeutics raised?
PineTree Therapeutics has raised $47.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
Who are PineTree Therapeutics's investors?
PineTree Therapeutics's investors include Smilegate Investment, Korea Investment Partners, SGI Venture Capital, STIC Investment, InterVest Co..
Where is PineTree Therapeutics headquartered?
PineTree Therapeutics is headquartered in Cambridge, United States.
What does PineTree Therapeutics do?
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
What stage is PineTree Therapeutics at?
PineTree Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"PineTree Therapeutics — Funding & Investors." VCBacked, October 28, 2025, https://www.vcbacked.co/company/pinetree-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2025). PineTree Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/pinetree-therapeutics
Wikipedia (cite web)
{{cite web |title=PineTree Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pinetree-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K